YahooSeptember 4, 2026 at 6:10 AM NY9 hours ago

Market Chatter: Bristol Myers Squibb Paused Zola-Cel Trials Over Safety Concerns

Bristol Myers Squibb (BMY) has told regulators, researchers and patient groups in early June that it

Read the Full Story at the Source

The summary here comes from the news provider; the rest of the article lives on the publisher's site — Yahoo

Companies in This Story